1586. Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy and Safety Outcomes Through Week 96 by Race

por Patel, Parul, Elliot, Emilie, D’Amico, Ronald, Garside, Louise, Smith, Conor, Roberts, Jeremy, Polli, Joseph W, Ramgopal, Moti, Kumar, Princy N, Osiyemi, Olayemi, Baugh, Bryan, van Wyk, Jean A
Publicado 2022